| Product NDC: | 37000-690 |
| Proprietary Name: | Vicks DayQuil |
| Non Proprietary Name: | Dextromethorphan Hydrobromide and Guaifenesin |
| Active Ingredient(s): | 10; 200 mg/15mL; mg/15mL & nbsp; Dextromethorphan Hydrobromide and Guaifenesin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | LIQUID |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 37000-690 |
| Labeler Name: | Procter & Gamble Manufacturing Company |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part341 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20090714 |
| Package NDC: | 37000-690-12 |
| Package Description: | 354 mL in 1 BOTTLE, PLASTIC (37000-690-12) |
| NDC Code | 37000-690-12 |
| Proprietary Name | Vicks DayQuil |
| Package Description | 354 mL in 1 BOTTLE, PLASTIC (37000-690-12) |
| Product NDC | 37000-690 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Dextromethorphan Hydrobromide and Guaifenesin |
| Dosage Form Name | LIQUID |
| Route Name | ORAL |
| Start Marketing Date | 20090714 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Procter & Gamble Manufacturing Company |
| Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN |
| Strength Number | 10; 200 |
| Strength Unit | mg/15mL; mg/15mL |
| Pharmaceutical Classes |